https://www.pharmaceutical-technology.com/news/china-approval-sinovac-vaccine/ 2021-02-08T08:49:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/bidens-covid-stimulus-full-employment/ 2021-02-08T07:31:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/us-drug-prices-rise-2021-reversing-trend-html/ 2022-02-22T09:00:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/accelerating-clinical-trials/how-a-drug-development-plan-can-save-your-biotech-money/ 2024-03-05T17:20:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/market-access-orphan-drug-at-risk/ 2021-02-05T17:01:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-near-105-million-israel-vaccination-results-show-promise/ 2021-02-05T14:11:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rolling-review-novavax-vaccine/ 2021-02-05T13:52:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jak-inhibitors-sales-increase-covid/ 2021-02-05T11:36:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/buying-our-way-clear-of-covid/ 2021-02-05T11:31:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-approves-astrazeneca-forxiga/ 2021-02-05T11:19:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/swifter-vaccination-programmes-covid/ 2021-02-05T10:52:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-near-105-million-us-fears-superbowl-spike-as-40000-die-in-two-weeks/ 2021-02-05T10:27:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/loa-update-beigenes-phase-iii-tislelizumab-for-esophageal-squamous-cell-carcinoma-sees-10-point-jump-for-fda-approval-forecast/ 2022-08-11T12:55:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/loa-update-agios-phase-iii-mitapivat-sulphate-for-pyruvate-kinase-deficiency-sees-12-point-rise-in-us-approval-prospects/ 2021-02-05T09:36:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/quercis-enlists-clinipace-for-phase-iii-trial-in-pancreatic-cancer-related-venous-thromboembolism-in-40m-60m-fundraise-ceo-says/ 2023-01-24T16:13:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-jj-submits-eua-to-fda-for-covid-19-vaccine-regulators-start-a-rolling-review-of-novavaxs-vaccine/ 2021-02-05T09:07:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-eua-vaccine-fda/ 2021-02-05T09:26:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/covaxx-commissions-cro-ppd-for-phase-ii-iii-covid-19-vaccine-trial-in-brazil-ceo-says/ 2023-01-24T16:13:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/bioeclipse-to-welcome-cro-cmo-pitches-from-midyear-for-phase-ii-in-advanced-solid-tumour-basket-trial-ceo-says/ 2023-01-24T16:14:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gut-microbiome-covid-19/ 2021-02-05T09:00:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/plymouth-looks-to-ride-brexit-and-covid-storm/ 2021-02-04T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/softgel-and-creating-the-next-super-pill/ 2024-03-13T17:18:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/eu-az-vaccine-row-covid-19/ 2021-02-11T17:10:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-vaccine-authorisation-singapore/ 2021-02-04T13:45:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/birchbiomed-to-seek-a-cro-in-about-two-months-for-topical-scarring-study-ceo-says/ 2021-02-04T13:07:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-curevac-vaccine-collaboration/ 2021-02-04T12:06:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ripple-therapeutics-to-consider-75m-plus-ipo-in-2023-or-series-b-post-phase-ii-trial-data-says-ceo/ 2023-01-24T16:14:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-us-covid-death-toll-passes-450000-amid-warnings-that-it-could-exceed-600000/ 2021-02-04T11:08:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/pfizer-canada-criticized-over-push-for-lower-taxes/ 2021-02-04T09:58:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pfizer-paying-low-taxes/ 2021-02-04T09:50:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-gsk-and-curevac-team-up-to-develop-vaccines-against-emerging-covid-19-variants-singapore-approves-modernas-vaccine/ 2021-02-04T08:39:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vaxart-oral-vaccine-candidate/ 2022-03-24T09:20:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/guide-to-fdi-what-is-the-point-of-incentives/ 2021-02-03T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-malaysia/ 2021-02-03T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/pharma-weekly-jobs-snapshot-another-busy-recruitment-week-for-sanofi-and-genzyme/ 2021-02-03T17:19:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aeterna-zentaris-signs-agreement/ 2023-01-06T13:38:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-concern-as-brazil-passes-herd-immunity-threshold-but-infections-continue-to-rise/ 2021-02-03T14:11:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/tscan-tcr-t-cell-therapies-series-c 2021-02-04T08:40:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mexico-authorises-sputnik-v/ 2021-02-03T12:02:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-russias-sputnik-v-vaccine-was-over-90-effective-in-clinical-trials-novavax-collaborates-with-canada-to-manufacture-its-covid-19-vaccine/ 2021-02-03T09:19:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/saxenda-profiling-the-first-nhs-weight-loss-drug-for-a-decade/ 2024-03-28T11:46:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update/ 2021-02-03T09:04:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tiziana-foralumab-inflammation-trial/ 2021-02-03T12:04:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-sport-increased-covid-mortalities/ 2021-02-03T07:56:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/uk-government-ignores-advice-coronavirus/ 2021-02-03T07:45:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/opinion/sustainable-investment-isnt-perfect-but-neither-is-the-planet/ 2021-02-02T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/liverpool-looks-to-get-its-investment-message-right/ 2021-02-02T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-us-infusion-centres/ 2021-02-02T13:48:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/india-allocates-4-8bn-vaccination/ 2021-02-02T12:19:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/novavaxs-vaccine-covid19-results/ 2024-05-10T06:48:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-103-million-us-january-death-toll-exceeded-95500/ 2021-02-02T09:02:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-bayer-and-rentschler-separately-support-curevacs-covid-19-manufacturing-uk-orders-an-additional-40-million-doses-of-valnevas-covid-19-vaccine/ 2021-02-02T09:00:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-highlights-how-the-us-fails-to-re-skill-its-unemployed/ 2021-02-02T08:30:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/us-jobs-pandemic-2024-leading/ 2021-02-02T11:58:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ampio-inhaled-drug-trial/ 2023-01-24T16:15:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/chinese-fdi-hits-lowest-mark-since-2008/ 2021-02-01T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/the-rise-of-protectionist-fdi-regulations/ 2021-02-01T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-103-million-portugal-suffers-new-surge-citing-uk-variant/ 2021-02-01T15:01:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-pfizer-vaccine-production/ 2021-02-01T15:24:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-hypera-pharma/ 2021-12-02T08:24:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novartis-sandostatin-competition-acromegaly-market/ 2023-01-04T09:22:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biden-marijuana-legalisation-plans/ 2024-09-17T10:18:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/brazil-covid-transmission/ 2021-02-01T09:27:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-novartis-supports-manufacturing-of-pfizer-biontechs-covid-19-vaccine-ema-approves-astrazeneca-oxfords-covid-19-vaccine/ 2021-02-01T09:22:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-102-million-china-arrests-fake-vaccine-suspects/ 2021-02-01T09:06:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/merus-lilly-t-cells-biscpecifics 2021-02-01T09:05:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/why-increased-investment-in-covid-vaccine-manufacturing-is-still-important/ 2021-02-01T07:52:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/serum-institute-of-india-trials-covid-vaccine/ 2023-01-24T16:15:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/investments-vaccine-manufacturing/ 2021-02-02T12:00:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/top-five-ways-covid-19-influences-the-work-of-investment-promotion-agencies/ 2021-01-31T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fdi-drivers-and-domestic-markets-does-size-matter/ 2021-01-31T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/why-abu-dhabis-world-class-healthcare-ecosystem-is-thriving/ 2021-06-25T10:23:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-approves-astrazeneca-oxford-covid-19-vaccine/ 2021-02-01T09:43:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-covid19-vaccine-effective/ 2021-02-01T09:20:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/allarity-welcomes-cro-offers-for-phase-ii-iii-covid-19-trial-with-decisions-to-be-made-asap-ceo-says/ 2022-07-11T08:52:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ridgeback-mercks-molnupiravir-for-covid-19-has-moa-administration-advantages-but-phase-iia-faces-execution-obstacles-may-have-value-gaps/ 2021-02-04T12:22:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-infections-pass-101-5-million-deaths-near-2-2-million/ 2021-01-29T14:11:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/redhill-cosmo-opaganib-agreement/ 2021-01-29T12:54:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-the-nymi-band%ef%b8%8f-improves-data-integrity-and-compliance-in-active-worker-environments/ 2021-01-29T11:30:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/covid-deaths-per-population/ 2021-01-29T11:30:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-south-african-covid-variant-sweeps-across-african-continent-europe-suffers-vaccine-shortages/ 2021-01-29T10:57:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novavax-vaccine-uk-trial/ 2022-07-11T08:52:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-covid-is-driving-technology-into-an-economic-super-cycle/ 2021-01-29T08:41:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-novavax-publishes-positive-efficacy-results-for-its-covid-19-vaccine-valneva-begins-producing-its-covid-19-vaccine-to-support-scale-up/ 2021-01-29T08:21:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid19-pharma-image-makeover-reputation/ 2021-02-01T15:22:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-macroeconomic-influencers/ 2021-01-29T07:39:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-vaccine-eua-philippines/ 2021-01-29T08:06:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-china-is-enabling-an-environmental-crisis-in-the-balkans/ 2021-01-28T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/bridging-the-healthcare-research-gap-in-the-uae/ 2021-06-25T10:24:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-vaccine-manufacturing-disruptions/ 2022-07-18T06:17:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-exceed-100986000-france-faces-third-lockdown/ 2021-01-28T14:40:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aji-lenzilumab-manufacturing-humanigen/ 2021-01-28T13:08:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/spacs-scepticism-surge/ 2021-01-28T12:24:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-us-vaccine-supply/ 2021-01-28T11:45:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-vaccination-programme/ 2021-01-28T14:59:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-vaccination-programme-uk/ 2021-01-28T09:42:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-near-101-million-increased-bribery-and-corruption-worldwide-alleged/ 2021-01-28T09:22:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-sanofi-to-support-production-of-pfizer-biontech-covid-19-vaccine-gsk-lilly-and-vir-team-up-on-antibody-combination-therapies/ 2021-01-28T08:36:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-covid-is-helping-to-break-us-unions/ 2021-01-28T07:40:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-vir-gsk-trial/ 2021-01-28T11:42:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/companies-pandemic-lockouts-break-unions/ 2021-01-28T07:09:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-south-africa/ 2021-01-27T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/where-are-the-global-hotspots-for-mnc-subsidiaries/ 2021-01-27T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/pharma-jobs-weekly-snapshot-jj-subsidiaries-sales-marketing/ 2021-01-27T16:59:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/new-strategies-hcc-market/ 2022-01-20T20:33:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/covid-19-phase-iii-trial-of-eigers-interferon-to-start-pending-ongoing-10m-financing-primary-investigator-says/ 2022-07-11T08:52:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/traveres-sparsentan-approvable-but-experts-divided-on-its-first-line-use-in-focal-segmental-glomerulosclerosis/ 2022-08-26T11:07:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-100-3-million-uk-second-only-to-us-in-active-case-numbers/ 2021-01-27T13:21:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/digital-transformation-objectives-shift-towards-operations-enablement-and-innovation-amid-covid-19-pandemic-survey/ 2021-01-27T21:46:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/humanetics-receives-dod-funding/ 2021-01-27T13:06:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-uk-covid-related-deaths-pass-100000-worst-in-europe-100-million-infections-worldwide/ 2021-01-27T12:10:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/genomics-timeline/ 2021-01-27T18:08:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mundipharma-cidara-rezafungin-eu/ 2021-01-27T11:24:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/bharat-phase-iii-covid-19-vaccine-investigators-on-alert-for-dropouts/ 2021-01-27T11:20:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/market-traction-for-immunogens-phase-iii-mirvetuximab-in-targeted-ovarian-cancer-niche-hinges-on-practical-diagnostic-but-long-term-success-supported-by-experts/ 2021-01-27T11:15:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ey-cell-gene-therapies-covid19/ 2021-01-27T10:59:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/delaying-covid-19-vaccine-booster-rooted-in-some-clinical-data-versus-reducing-doses-but-neither-approach-likely-to-solve-distribution-quandaries/ 2021-01-27T09:30:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-eli-lillys-antibody-cocktail-reduced-covid-19-deaths-and-hospitalisations-iran-approves-russias-sputnik-v-vaccine/ 2021-01-27T09:14:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/why-virus-suppression-is-key-in-pandemic-exit-strategy/ 2021-01-27T08:59:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/us-schools-scant-transmission-coronavirus/ 2021-01-27T08:50:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iran-approves-sputnik-v/ 2021-01-27T10:07:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/pharma-healthcare-top-10-2021-and-beyond-html/ 2021-11-02T03:14:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/opinion/brexits-bum-note-mustnt-silence-the-uks-singers/ 2021-01-26T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fdi-between-israel-and-the-uae/ 2021-01-26T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-near-100-million-long-haul-symptoms-can-last-more-than-six-months/ 2021-01-26T14:24:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/genomics-regulatory-trends/ 2021-11-30T11:46:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-discontinue-two-vaccine/ 2021-01-26T12:30:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/culture-and-covid-loom-large-for-edinburgh/ 2021-01-25T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/unctad-figures-show-42-drop-for-fdi-in-2020/ 2021-01-25T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-99-3-million-us-tops-25-million/ 2021-01-25T16:28:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-vaccine-variants-covid19/ 2021-01-25T15:43:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/elasmogen-protein-drugs-covid-19/ 2021-01-28T07:29:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/telemedicine-to-benefit-the-most-from-remote-patient-monitoring-tools-poll/ 2022-07-11T08:52:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/companies-seek-to-improve-operational-efficiency-with-digital-transformation-survey/ 2021-02-04T08:26:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/covid-19-pandemic-led-to-increase-in-emerging-technology-investments-in-pharma-finds-survey/ 2021-01-27T18:12:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/adastra-eyes-cro-pitches-for-phase-ii-trial-of-anticancer-candidate-initiates-45m-series-b-fundraising-exec-says/ 2022-07-11T08:52:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-acquires-prevail-therapeutics/ 2022-03-24T10:34:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/genomics-technology-trends/ 2023-06-19T15:22:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-approach-100-million-as-daily-case-count-averages-650000/ 2021-01-25T09:29:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-pfizer-biontech-sign-a-40-million-supply-deal-with-covax-novavax-signs-supply-deal-with-canada/ 2021-01-25T09:28:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ms/ 2021-01-29T14:57:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/why-masks-and-restrictions-are-still-needed-to-beat-covid/ 2021-01-25T07:56:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-vaccine-rollouts/ 2021-01-25T07:27:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/most-read/australia-pfizer-biontech-vaccine/ 2021-01-25T09:41:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/brightons-future-hangs-in-the-balance/ 2021-01-24T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/orphazymes-arimoclomol-expected-to-be-used-with-zavesca-after-likely-fda-approval-in-niemann-pick-disease-type-c/ 2023-02-22T11:12:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/nihs-strategy-to-assess-modernas-covid-19-vaccine-at-half-dose-has-significant-stumbling-blocks-for-evidence-collection-and-analysis/ 2021-01-22T13:39:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/digital-therapeutics-germany/ 2023-06-07T04:40:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-97-6-million-eu-countries-face-50-vaccine-supply-cut/ 2021-01-22T12:35:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/lack-of-specific-skills-and-talents-one-of-the-four-top-obstacles-to-digital-transformation-in-companies-survey/ 2021-01-22T10:42:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/insufficient-funding-and-legacy-systems-two-of-the-top-four-obstacles-to-digital-transformation-survey/ 2021-01-22T10:39:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/turn-therapeutics-treatment-trial/ 2022-07-11T08:52:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-moderna-works-with-takeda-on-japan-vaccine-trial-sputnik-v-authorised-for-use-in-the-uae/ 2021-01-22T08:53:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/who-amr-global-laeaders-group/ 2021-01-27T11:31:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/lilly-drug-prevents-covid/ 2021-01-22T08:08:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uae-approves-sputnik-v/ 2021-01-22T09:43:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-tanzania/ 2021-01-21T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/the-biden-presidency-what-how/ 2021-01-21T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/jobs/pharma-jobs-weekly-snapshot-10-16-january/ 2021-01-21T16:58:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ptf-spotting-new-covid-19-variants-with-genome-mapping/ 2021-01-22T08:55:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fire-serum-institute-facility/ 2021-01-21T15:19:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-near-97-million-trending-down-in-usa-india-brazil/ 2021-01-21T14:57:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/lack-of-specific-skills-and-talents-main-obstacle-to-digital-transformation-survey/ 2021-01-21T14:46:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/pharmaceutical-industry-optimistic-about-the-growth-of-digital-transformation-over-the-next-12-months-survey/ 2021-01-21T14:46:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/akron-biotech-octapharma-serum/ 2021-01-21T14:00:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cross-eu-drug-supply-chain-to-be-most-affected-post-brexit-poll/ 2022-07-11T08:52:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adamis-submits-ind-fda/ 2023-03-10T05:39:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid19-variants-vaccines-next-generation/ 2021-02-18T14:10:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-deaths-reach-new-daily-high-vaccines-may-need-re-design-to-cope-with-new-variants/ 2021-01-21T08:58:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-pfizer-biontech-covid-19-vaccine-found-to-be-effective-against-uk-variant-gc-pharma-moves-closer-to-submitting-a-eua-in-korea-for-its-plasma-covid-19-therapy/ 2021-01-21T08:58:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-pfizer-vaccine-variant/ 2021-01-21T08:54:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pandemic-catastrophy-women-canada/ 2021-01-21T07:14:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/eu-countries-covid19-vaccination-race-supply-html/ 2021-11-02T03:14:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/mapi-pharma-engages-pra-health-sciences-as-cro-for-phase-iii-multiple-sclerosis-trial/ 2022-07-11T08:52:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/pre-clinical-and-clinical-trial-processes-likely-to-benefit-most-from-digital-transformation-survey/ 2021-01-20T15:27:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/larger-and-small-firms-turn-to-operations-enablement-and-innovation-following-covid-19-survey/ 2021-01-21T14:45:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-96-2-million-israel-leads-vaccinations/ 2021-01-20T14:09:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/tonix-oxytocin-metabolic-disorders/ 2023-05-22T08:41:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gritstone-niaid-enter-agreement/ 2021-01-20T15:54:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-merus-partner-therapies/ 2021-01-20T11:46:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-trump-covid-and-brexit-boosted-canadas-talent-pool/ 2021-01-20T10:58:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/canada-talent-pool/ 2021-01-20T09:54:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-us-covid-deaths-exceed-400000-global-infections-pass-96-1-million/ 2021-01-20T09:14:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-iraq-authorises-astrazeneca-university-of-oxford-and-sinopharmas-vaccines-russia-reports-its-second-covid-19-vaccine-is-100-effective-in-phase-i-and-ii-studies/ 2021-01-20T08:50:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cdsco-panel-bharat-biotech/ 2021-01-20T08:21:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/frewitt-technical-center/ 2022-05-11T09:45:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/what-is-in-store-for-fdi-post-covid-and-beyond/ 2021-01-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/will-biden-punish-britain-for-brexit/ 2021-01-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-election-aca-medicare/ 2021-01-19T16:03:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/covid-19-pandemic-increased-virtual-engagement-with-physicians/ 2021-01-19T15:21:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/digital-transformation-to-benefit-marketing-and-sales-departments-survey/ 2021-01-19T15:18:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-us-covid-death-toll-nears-400000-uk-deaths-exceed-90000/ 2021-01-19T13:57:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/syntegra-collaborates-with-nih/ 2021-01-19T13:29:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/enara-boehringer-ingelheim-dark-antigens-oncology-partnership 2021-01-21T15:21:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aruvant-partners-with-lonza/ 2021-01-19T12:00:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-95-6-million-who-slams-vaccine-profiteers/ 2021-01-19T09:47:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pfizer-opko-somatrogon-fda/ 2021-11-22T07:32:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-turkmenistan-approves-sputnik-v-vaccine-pakistan-approves-its-second-covid-19-vaccine-developed-by-sinopharm/ 2021-01-19T08:55:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-bidens-1-9t-stimulus-package-will-help-tackle-covid/ 2021-01-19T07:57:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pakistan-grants-eua-sinopharm/ 2021-01-19T07:53:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/biden-stimulus-plan/ 2021-01-19T07:16:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/biden-wont-solve-us-fdi-woes/ 2021-01-18T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-deaths-exceed-2-million-as-who-asks-for-greater-co-operation/ 2021-01-18T14:53:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/thermo-fisher-acquires-henogen/ 2021-01-18T13:52:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/uk-highest-number-covid-cases/ 2021-01-18T13:48:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/forxiga-review-designation-ckd/ 2021-01-18T13:27:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/digital-transformation-survey-finds-misalignment-declining-among-senior-executives-and-employees/ 2021-01-19T15:14:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/norway-concern-pfizer-vaccine/ 2021-06-01T08:45:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-brazil-approves-two-covid-19-vaccines-one-by-sinovac-the-second-by-astrazeneca-oxford-astrazeneca-oxford-vaccine-emergency-approved-in-nepal/ 2021-01-18T09:07:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-deaths-pass-2-million-norway-investigates-post-vaccination-deaths/ 2021-01-18T08:49:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/amazon-pharmacy-disruption-healthcare/ 2021-10-29T07:03:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brazil-approves-sinovac-astrazeneca/ 2021-02-08T07:53:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-co-operation-vital-for-covid-recovery/ 2021-01-18T07:03:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/global-cooperation-covid-recovery/ 2021-01-18T06:55:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/joe-biden-and-the-future-of-us-manufacturing/ 2021-01-17T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/azurrx-engages-cros-rho-and-linical-in-separate-phase-ii-trials-in-cystic-fibrosis-with-pancreatic-insufficiency/ 2022-07-11T08:52:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/revitope-oncology-welcomes-cro-and-cmo-pitches-in-several-months-for-phase-i-trial-and-drug-development/ 2022-07-11T08:52:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-93-2-million-china-builds-new-quarantine-facility/ 2021-01-15T18:14:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/a-standard-approach-to-drug-development-for-accessing-the-globe/ 2024-07-01T16:07:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/israel-covid-19-vaccinations/ 2023-03-14T10:16:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newamsterdam-pharma-raises-196m/ 2022-12-02T12:38:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/phesi-sensyne-synthetic-control-arms 2021-01-15T13:43:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-pfizer-xalkori/ 2021-01-15T11:46:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-deaths-near-2-million-as-cases-pass-93-million/ 2021-01-15T10:44:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/myovant-sciences-pfizer-relugolix/ 2021-11-23T08:11:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/biden-announces-american-rescue-plan-uk-free-school-meals-row-continues/ 2021-01-15T08:48:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-pfizer-biontechs-covid-19-vaccine-approved-in-the-philippines-us-fda-awards-fast-track-designation-to-innovations-covid-19-drug/ 2021-01-15T08:39:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/biden-unveils-covid-relief-plan/ 2021-01-15T08:25:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sii-who-vaccine-approval/ 2021-01-15T11:01:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-trump-lost-his-war-on-fdi/ 2021-01-14T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-exceed-92-million-uk-death-count-nears-85000-worst-in-europe/ 2021-01-14T14:20:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/pharma-jobs-weekly-snapshot-3-9-janaury/ 2021-01-14T15:36:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/genomics-covid19-real-time-surveillance-viral-mutations-variants/ 2021-01-14T12:54:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/disease-cancelling-drugs-immuneering-raises-62m-in-series-b-round 2021-01-13T17:14:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-infections-pass-91-7-million-japan-reports-new-variant/ 2021-01-13T14:27:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-cancer-deal-enara-bio/ 2021-01-13T14:22:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/healthcare-sector-could-take-more-than-three-years-to-stabilise-in-the-event-of-no-deal-brexit-poll/ 2022-07-19T11:49:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sentiment-about-post-brexit-impact-on-the-uk-healthcare-sector-worsens-since-the-onset-of-covid-19-poll/ 2022-01-18T18:54:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/covid-19-affected-clinical-trial-planning-survey/ 2021-01-13T12:41:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/scripps-institute-conducts-study-to-facilitate-detection-of-covid-19/ 2021-01-13T12:28:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-priority-review-merck-v114/ 2021-01-13T11:05:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-91-6-million-concerns-raised-over-vaccine-efficacy/ 2021-01-13T09:15:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/novavaxs-south-african-phase-iib-covid-19-vaccine-trial-likely-to-reveal-results-within-next-fortnight-source-says/ 2024-06-18T10:02:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-switzerland-approves-modernas-covid-19-vaccine-us-hhs-and-dod-secure-supply-of-regenerons-antibody-drug-cocktail-for-hospitalised-covid-19-patients/ 2021-01-13T09:00:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/brazil-coronavac-data-questions-covid-vaccine-efficacy/ 2021-01-13T08:22:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/switzerland-authorises-moderna-vaccine/ 2021-01-13T11:18:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/brazil-reports-modest-efficacy-coronavac/ 2021-01-13T08:07:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-the-brexit-deal-means-for-manufacturing/ 2021-01-12T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-companies-can-thrive-post-covid-an-11-point-plan/ 2021-01-12T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cohbar-niaid-cb5064-analogs/ 2021-01-12T14:32:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-near-91-million-growing-concern-over-surge-across-europe/ 2021-01-12T14:22:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-to-acquire-kymab/ 2021-01-12T11:01:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-near-91-million-herd-immunity-not-achievable-in-2021-say-who/ 2021-01-12T09:07:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/biopharma-ey-ma-analysts-optimistic-for-2021-deals-after-a-mixed-2020 2022-03-22T06:06:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-neurorx-relief-and-quantum-leap-team-up-on-i-spy-covid-19-trial-indonesia-approves-sinovacs-covid-19-vaccine/ 2021-01-12T08:44:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/us-healthworkers-face-covid-vaccination-uncertainty/ 2021-01-12T08:18:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/codagenix-sii-dosing-vaccine/ 2021-01-12T11:58:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/us-rapid-decline-labour-force/ 2021-01-12T07:06:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-lebanon/ 2021-01-11T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/sdg-focus-can-fdi-revive-covid-hit-gender-targets/ 2021-01-11T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/british-columbia-rejects-bamlanivimab/ 2021-01-11T14:13:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-90-3-million-uk-averaging-almost-61000-daily/ 2021-01-11T13:34:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/humanigen-eversana-collaborate-drug/ 2021-01-11T11:35:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-one-year-since-first-covid-death-announced-the-global-toll-nears-2-million/ 2021-01-11T10:05:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/uk-covid-19-vaccine-rollout-dosing-schedule/ 2021-01-11T10:13:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-uk-approves-modernas-covid-19-vaccine-covaxx-starts-studying-a-new-vaccine-that-tackles-emerging-viral-mutations-and-variants/ 2021-01-11T09:12:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/algeria-registers-sputnik-v/ 2021-01-11T07:49:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-covid-will-slow-human-capital-development/ 2021-01-11T07:20:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-human-capital-development/ 2021-01-11T07:51:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/covid19-rd-tracker-vaccine-rollouts-dosing-controversies-strain-html/ 2021-11-02T03:17:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-variant-south-africa/ 2021-01-08T16:46:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/covid-19-variants-pfizer-biontech-vaccine-effective/ 2021-01-08T16:00:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/business-optimism-improves-in-december-amid-covid-19-vaccine-rollout-poll/ 2021-01-08T15:50:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-approves-moderna-covid-19-vaccine/ 2021-06-01T09:14:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-to-acquire-amptec/ 2021-01-08T14:16:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-may-adopt-a-model-similar-to-that-of-other-countries-upon-brexit-poll/ 2021-01-13T13:08:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/kinsa-health-utilises-smart-thermometers-for-predicting-covid-19-outbreaks/ 2021-01-08T13:32:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-exceed-88-1-million-uk-nears-3-million/ 2021-01-08T13:29:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/oura-smart-ring-enables-early-detection-of-covid-19/ 2021-01-08T13:23:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/renovorx-in-10m-20m-series-c-fundraising-mode-for-phase-iii-pancreatic-cancer-trial-ceo-says/ 2022-07-11T08:52:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-study-arthritis-drugs/ 2021-01-08T11:08:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/company-coronavirus-news-summary-curevac-teams-up-with-bayer-to-support-its-covid-19-vaccine-bharat-biotech-completes-recruitment-for-its-phase-iii-vaccine-trial/ 2021-01-08T08:17:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/rwanda-leads-battle-against-covid-pandemic/ 2021-01-08T08:09:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/rwanda-covid/ 2021-01-08T08:02:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/patient-consumerism-timeline/ 2022-07-11T08:52:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/am-pharma-enrols-patients/ 2022-07-11T08:52:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-vietnam/ 2021-01-07T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-to-increase-efficiency-and-agility-in-oncology-trials/ 2021-06-21T08:16:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/covid-19-to-trigger-digital-transformation-in-pharmaceutical-industry/ 2021-01-07T14:44:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-signs-deal-curevac/ 2021-10-21T11:09:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/biofourmis-platform-used-in-hong-kong-for-monitoring-covid-19-patients/ 2021-01-08T13:15:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/patient-consumerism-regulatory-trends/ 2021-01-07T11:08:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/university-glasgow-establish-hub/ 2021-01-07T10:36:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-china-stalls-who-global-covid-cases-pass-87-2-million/ 2021-01-07T10:15:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/company-coronavirus-news-summary-modernas-covid-19-vaccine-approved-in-europe-morocco-approves-astrazeneca-oxford-covid-19-vaccine/ 2021-01-07T09:23:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-covid-could-stoke-civil-unrest-in-the-us/ 2021-01-07T09:12:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/rising-unemployment-rates-likely-to-cause-violent-unrest-in-the-us-leading-macroeconomic-influencers/ 2021-01-07T08:41:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vaccine-moderna-european-commission/ 2021-01-07T13:44:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/does-foreign-aid-promote-investment/ 2021-01-06T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cellid-vaccine-research-contract/ 2021-01-06T13:11:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/huma-unveils-covid-19-version-of-rpm-platform/ 2021-01-06T12:45:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/digital-transformation-gathers-pace-in-healthcare-industry-finds-a-survey/ 2021-01-06T12:44:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/akston-lakepharma-covid-vaccine/ 2021-01-11T10:53:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-akston-and-lakepharma-partner-on-second-generation-covid-19-vaccine-emergex-vaccines-partners-with-oswaldo-cruz-foundation-to-study-covid-19-vaccine-in-brazil/ 2021-01-06T09:22:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-singapore-police-use-covid-contact-tracing-data-in-murder-investigation-global-covid-infections-pass-86-4-million/ 2021-01-06T08:21:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/colombia-approval-pfizer-biontech/ 2021-01-06T09:43:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/patient-consumerism-macroeconomic-trends/ 2021-01-05T12:41:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/starmer-challenges-johnson-to-deliver-on-vaccinations/ 2021-01-06T07:21:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/lawmakers-push-billionaires-tax/ 2021-01-06T07:17:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-albania/ 2021-01-05T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/az-oxford-vaccine-uk-rollout-deep-dive/ 2024-09-17T10:18:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/remote-patient-monitoring-surges-amid-covid-19-pandemic-case-study/ 2021-01-05T14:51:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-divests-atacand-cheplapharm/ 2021-01-05T14:22:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/small-molecule-api-strategies-of-pharmaceutical-companies-not-to-change-despite-covid-19-survey/ 2021-01-05T12:32:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/patient-consumerism-technology-trends/ 2022-07-11T08:52:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-85-7-million-pfizer-warn-against-booster-delays-north-korea-asks-for-help/ 2021-01-05T10:58:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/israel-authorises-moderna-vaccine/ 2021-01-05T10:33:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-modernas-vaccine-is-approved-in-israel-inovio-signs-an-agreement-with-advaccine/ 2021-01-05T08:52:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-covid-is-driving-the-us-property-market/ 2021-01-05T07:24:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/us-rise-home-prices-covid/ 2021-01-05T07:19:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/atyr-pharma-drug-trial/ 2022-07-11T08:52:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fdi-drivers-clusters-and-the-power-of-community/ 2021-01-04T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/pharma-manufacturing-network-likely-to-remain-unscathed-despite-covid-19-survey/ 2021-01-04T12:33:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/covid-19-risks-moderately-considered-when-awarding-suppliers-finds-survey/ 2021-01-04T12:26:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-exceed-85-million-us-records-20-6-million-global-deaths-approach-2-million/ 2021-01-04T11:25:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/injectable-anti-hiv-therapies-japan/ 2023-01-09T04:09:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-india-grants-emergency-approval-to-two-covid-19-vaccines-brazil-to-import-two-million-doses-of-az-vaccine/ 2021-01-04T14:41:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/serum-bharat-biotech-vaccines/ 2021-10-29T05:28:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/why-harder-covid-lockdowns-protect-economies/ 2021-01-04T07:39:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/strict-measures-control-covid/ 2021-01-04T07:33:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-algeria/ 2021-01-03T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-approves-astrazeneca-vaccine/ 2020-12-30T10:09:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-oxford-vaccine-eu/ 2020-12-30T06:41:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/companies-increase-inventories-in-response-to-covid-19-related-disruptions-survey/ 2020-12-30T06:11:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/covid-19-related-disruption-planning-highest-among-north-american-companies-survey/ 2020-12-30T06:02:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/covaxx-aurobindo-sign-deal/ 2021-10-28T07:49:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/oblato-open-to-cro-pitches-for-paediatric-cancer-candidate-okn-007-exec-says/ 2020-12-29T08:56:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/pharma-companies-turning-to-remote-patient-monitoring-for-clinical-trials-amid-covid-19-finds-survey/ 2020-12-29T05:17:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/covid-19-impacting-patient-recruitment-for-clinical-trials-survey/ 2020-12-29T04:52:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-thailand/ 2020-12-28T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/pharma-deals-november-snapshot-china-mega-merger-tops-the-chart 2021-01-04T05:40:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/enrolment-suspensions-main-cause-for-disruption-of-clinical-trials-survey/ 2020-12-28T10:25:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/covid-19-effect-patient-recruitment-most-affected-in-clinical-trial-planning-across-regions/ 2020-12-28T10:19:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/russia-sputnik-senior-citizens/ 2020-12-28T08:35:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/tg-therapeutics-umbralisib-ublituximab-likely-to-face-market-hurdles-but-fda-approval-highly-expected/ 2021-11-25T10:13:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/glaxosmithkline-vir-biotechnologys-and-astrazeneca-mabs-eyed-in-early-covid-19/ 2020-12-25T10:27:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/dicernas-best-hope-for-nedosiran-use-likely-in-non-responders-to-alnylams-oxlumo-in-primary-hyperoxaluria-type-1/ 2020-12-25T09:48:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/argentina-registers-sputnik-v/ 2020-12-24T14:23:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-biontech-vaccine-us/ 2020-12-24T11:49:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/dexcom-t2d-tv-ads/ 2021-01-08T09:36:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/toralgen-t2d-therapy-fda-etp/ 2020-12-24T10:31:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/covid-19-risk-to-import-export-of-finished-dose-and-apis-minor-say-companies/ 2020-12-24T09:56:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/commercial-supply-chain-risks-api-chemical-logistics-transportation-survey/ 2020-12-24T04:40:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-vaccine-health-canada/ 2020-12-24T11:39:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/rigenerand-engages-cro-coresearch-for-phase-i-gene-therapy-study-in-pancreatic-cancer-executive-says/ 2022-01-24T13:31:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/tvax-raising-15m-for-phase-ii-study-of-gbm-candidate-ceo-says/ 2020-12-24T06:00:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/reddys-health-canada-treatment/ 2020-12-23T14:54:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/scientists-say-new-uk-strain-may-not-affect-covid-19-vaccines-efficacy/ 2020-12-23T12:17:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bharat-biotech-ocugen-vaccine/ 2020-12-23T11:52:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/logistics-and-transport-main-concern-related-to-clinical-trial-supply-chain-survey-results/ 2020-12-23T10:15:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/companies-addressing-import-export-supply-chain-risks-coronavirus-survey/ 2020-12-23T10:14:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/self-medication-future-of-pharma/ 2020-12-18T12:11:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/redhill-gets-dsmb-recommendation/ 2020-12-23T11:50:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-pennsylvania/ 2020-12-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/top-five-trends-in-fdi-to-look-out-for/ 2020-12-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hcc-asia-pacific-high-burden/ 2020-12-22T15:16:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-divest-assets-hasten/ 2020-12-22T14:14:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-covid-19-has-accelerated-digital-health-and-the-evolution-of-clinical-trials/ 2020-12-24T11:58:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/are-healthcares-sustainability-goals-bold-enough/ 2020-12-22T12:29:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-uruguay-success/ 2020-12-22T12:34:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/servier-oncology-business-agios/ 2021-11-22T12:57:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/developing-a-new-biologic-drug-regulatory-challenges-and-considerations/ 2024-07-01T16:17:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/who-says-new-variant-of-covid-19-virus-in-uk-not-out-of-control/ 2020-12-22T08:18:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/covid-19-monitor-import-export-and-supply-chain-risks-survey/ 2020-12-22T07:31:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approval-pfizer-vaccine/ 2020-12-22T11:16:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/covid-19-revenue-impact-highest-apac-companies-survey/ 2020-12-22T07:20:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-77-million-sweden-joins-countries-banning-travel-from-uk/ 2020-12-22T06:48:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-singapore/ 2020-12-21T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-allergic-reactions-pfizer/ 2020-12-21T14:43:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-close-in-on-77-million-sharp-rise-for-uk-as-infections-pass-2-million/ 2020-12-21T14:00:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/employee-safety-and-supply-chain-impact-primary-business-concerns-related-to-covid-19-outbreak-survey/ 2020-12-21T22:54:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/daria-donati-uk-vmic/ 2021-01-21T09:12:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-identifies-new-strain/ 2020-12-21T11:45:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-near-77-million-new-variant-prompts-travel-restrictions/ 2020-12-21T11:44:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/accelerating-clinical-trials/the-benefit-of-running-clinical-trials-in-asia-pacific-for-biotech-companies/ 2024-03-05T17:19:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ptf-is-joe-biden-good-news-for-us-pharma/ 2020-12-21T11:14:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-cdc-moderna-vaccine/ 2020-12-21T11:36:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/surveys-dashboards/primary-business-concerns-related-to-covid-19-outbreak-by-company-type-survey/ 2020-12-21T22:56:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/swansea-taps-local-resources-for-economic-renewal/ 2024-04-04T03:49:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-suriname/ 2024-04-04T03:50:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/oncosecs-tavo-potential-in-tnbc-depends-on-administration-operability-and-impact-on-metastases/ 2020-12-24T05:48:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/evelos-gut-stimulating-bacteria-approach-for-derma-diseases-evokes-expert-reservations/ 2020-12-24T05:49:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/karyopharms-selinexor-combination-multiple-myeloma/ 2021-11-23T11:29:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/icr-create-3d-structure/ 2020-12-18T14:23:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-75-million-who-scientists-to-visit-wuhan/ 2020-12-18T13:50:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/agenus-collaborating-with-cro-parexel-for-phase-ii-oncology-basket-trial/ 2020-12-24T05:52:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-75-million-putin-signals-caution-over-sputnik-vaccine/ 2020-12-18T12:26:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/viagra-competition-q3-sales/ 2020-12-18T10:20:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-sponsored-trials-antibodies/ 2022-07-11T08:52:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/future-of-research-webinar-series-publication-and-pre-print-challenges-in-the-covid-era/ 2021-01-05T15:22:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-vaccine-pfizer-biontech/ 2020-12-18T12:45:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/why-us-jobs-recovery-is-covid-vaccine-dependant/ 2020-12-18T09:40:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/uk-extends-covid-job-subsidy/ 2020-12-18T10:59:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fast-track-vaccine-qa-ucl/ 2020-12-16T11:58:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-moderna-covid-vaccine/ 2020-12-18T07:57:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-paraguay/ 2024-04-04T03:51:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/war-and-peace-and-fdi/ 2024-04-04T03:52:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-to-acquire-cadent/ 2020-12-17T15:42:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/healthcare-5-0-reimagined/ 2021-06-25T10:24:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/m-a-activity-remains-high/ 2020-12-18T09:00:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-74-million-deaths-exceed-1-6-million/ 2020-12-17T13:48:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-fosun-vaccine-china/ 2021-10-27T12:47:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-74-million-brazil-cases-top-7-million/ 2020-12-17T09:02:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-covid-is-fuelling-a-humanitarian-crisis-in-zimbabwe/ 2020-12-17T08:25:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bharat-biotech-covaxin-trial/ 2022-07-11T08:52:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/zimbabwe-children-malnourished-covid/ 2020-12-17T08:11:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/new-zealand-trials-post-covid-19/ 2022-07-11T08:52:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/revelation-series-a-covid-19-therapy/ 2020-12-17T05:17:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-the-drc/ 2024-04-04T03:52:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-drug-infusion-devices-can-benefit-from-using-silicone/ 2022-02-23T10:40:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-acquire-prevail-therapeutics/ 2020-12-16T15:36:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-73-6-million-ema-vaccine-approval-meeting-pulled-forward/ 2020-12-16T14:57:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-exceed-73-5-million-us-hospitalizations-on-the-rise/ 2020-12-16T11:50:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/artios-merck-group-ddr-drug-discovery 2020-12-16T11:47:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gavi-salesforce-vaccine-distribution/ 2020-12-16T11:19:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-report-moderna-vaccine/ 2020-12-16T12:09:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-the-gig-economy-helps-spread-covid-in-nursing-homes/ 2020-12-16T08:08:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/nursing-home-workers-covid-transmission/ 2020-12-16T07:55:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/anti-counterfeit-packaging-pharma/ 2023-05-12T10:17:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/byondis-commercialisation-partner-breast-cancer-adc/ 2021-10-27T12:26:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cardiff-plays-clever-to-attract-fdi/ 2024-04-04T03:54:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-73-million-us-infections-pass-16-5-million/ 2020-12-15T17:12:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/singapore-pfizer-biontech-vaccine/ 2020-12-15T15:08:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-near-73-million-new-covid-variant-identified-in-south-east-england/ 2020-12-15T14:21:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/frontier-abbvie-undruggable-proteins 2020-12-15T14:45:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pancreatic-cancer-japan/ 2022-10-14T12:55:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eureka-nasal-spray-studies/ 2020-12-15T09:38:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/gates-foundation-exscientia-ai-global-health-challenges 2020-12-15T12:50:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/curevac-initiates-vaccine-trial/ 2022-07-11T08:52:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-vaccines-are-arriving-and-so-are-new-problems/ 2020-12-15T07:10:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/oregon-first-coronavirus-vaccines/ 2020-12-15T06:50:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-the-philippines/ 2024-04-04T03:55:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/has-covid-19-dented-swfs-fdi-appetite/ 2024-04-04T03:55:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-covid-digital-space/ 2020-12-14T17:20:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-to-acquire-alexion/ 2021-10-27T12:24:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/dwarfism-drug-biomarin/ 2021-11-30T11:41:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/south-korea-biologics-production/ 2022-01-19T13:43:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-pandemic-icu-us/ 2020-12-14T14:43:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-72-3-million-deaths-exceed-1-6-million/ 2020-12-14T13:46:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bahrain-approves-sinopharm-vaccine/ 2020-12-14T10:33:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-72-25-million-brazil-population-pushes-back-on-vaccines/ 2020-12-14T10:00:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-conspiracy-theories-and-politics-could-derail-covid-vaccine-programmes/ 2020-12-14T08:05:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/why-is-president-elect-joe-biden-a-good-pick-for-the-pharma-industry/ 2020-12-14T12:15:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/europeans-distrust-covid-vaccines/ 2020-12-14T07:43:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-pfizer-biontech-vaccine/ 2020-12-14T10:24:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-bolivia/ 2024-04-04T03:56:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/glasgow-resurgence-remains-on-track/ 2024-04-04T03:59:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/university-of-oxford-blueprint-covid-19-vaccines/ 2020-12-12T05:56:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-buy-nbe-therapeutics/ 2020-12-11T15:56:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novartis-opthalmology-technologies/ 2023-05-23T05:27:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-gsk-covid-19-vaccine-trial-delay/ 2023-01-24T16:35:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-infections-pass-69-7-million-germany-considers-full-lockdown/ 2020-12-11T12:13:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/noema-rare-neurological-diseases 2020-12-10T10:31:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-sciences-acquire-myr/ 2020-12-11T14:34:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-approach-70-million-australia-terminates-vaccine-agreement/ 2020-12-11T09:36:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/company-coronavirus-news-summary-pfizer-moves-one-step-closer-to-emergency-approval-in-the-us-moderna-does-adolescents-into-its-phase-ii-iii-study/ 2020-12-11T09:12:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-covid-has-hit-humanitarian-aid-programs/ 2020-12-11T08:48:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/humanitarian-relief-funding-deficit/ 2020-12-11T08:37:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-biontech-fda-authorisation/ 2020-12-11T12:02:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/hepatitis-hcv-timeline-nobel-prize/ 2020-12-09T11:43:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/polyphors-balixafortide-activity-advanced-her2-negative-hr-metastatic-breast-cancer/ 2022-01-20T20:44:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/state-of-play-fdi-in-haiti/ 2020-12-10T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/rheumatoid-arthritis-treatment-options/ 2022-10-03T12:09:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pharma-companies-should-partner-with-specialist-technology-firms-to-capitalize-on-big-data-and-ai/ 2020-12-10T16:48:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arcus-wuxi-expand-deal/ 2021-11-22T07:39:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-69-million-japan-hit-by-third-wave/ 2020-12-10T13:34:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-to-acquire-labor/ 2020-12-10T11:33:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/medical-industry-racism-covid-19/ 2021-01-21T09:11:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/five-pipeline-agents-ra-market/ 2022-11-29T15:40:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/one-off-wealth-tax-to-aid-covid-recovery-proposed-for-uk/ 2020-12-10T09:17:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-canada-grants-emergency-approval-to-pfizer-biontechs-vaccine-sinopharms-vaccine-achieves-86-efficacy-in-uae-trials/ 2020-12-10T09:08:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-approach-70-million-anti-vaxxers-push-back-in-us-and-france/ 2020-12-10T09:04:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-vaccine-data-adults-forecasts/ 2020-12-10T09:00:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/indoor-dining-low-income/ 2020-12-10T10:41:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/brewprint-using-yeast-to-make-plant-based-drugs-2/ 2020-12-10T10:32:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-pfizer-covid-19/ 2020-12-10T06:58:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-cyprus/ 2024-04-04T04:00:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/dundee-continues-on-its-quest-for-discovery/ 2024-04-04T04:02:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-making-of-a-global-healthcare-destination-how-abu-dhabi-built-a-thriving-partnership-with-mayo-clinic/ 2021-06-25T10:24:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid19-vaccine-allergic-reactions/ 2020-12-10T10:46:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jd-online-healthcare-alibaba/ 2020-12-09T14:35:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-vaccine-effective-covid/ 2020-12-09T14:23:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-exceed-68-3-million-continued-surge-in-south-korea/ 2020-12-09T13:01:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-68-3-million-more-than-15-1-million-in-us/ 2020-12-09T11:21:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bharat-biotech-intranasal-vaccine/ 2020-12-09T12:43:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/company-coronavirus-news-summary-astrazeneca-signs-vaccine-manufacturing-agreement-with-halix-moderna-expands-supply-deal-with-switzerland/ 2020-12-09T09:26:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/house-prices-to-rise-in-spite-of-covid/ 2020-12-09T08:31:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/house-prices-macroeconomic-influencers/ 2020-12-09T12:59:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/gold-standard-why-are-phase-iii-trials-so-critical/ 2023-01-24T16:35:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-slovakia-testing/ 2020-12-09T14:02:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-pfizer-biontech-safety/ 2020-12-09T12:20:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/esg-tendering-landscape-variation-top5-europe-html/ 2021-11-02T03:18:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-guyana/ 2024-04-04T04:04:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-infections-pass-67-7-million-vaccinations-begin-in-uk/ 2020-12-08T14:28:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-initiate-covid-19-vaccination/ 2020-12-09T13:36:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/janssen-pp6m-schizophrenia/ 2020-12-08T13:06:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-biobank-studies-proteins/ 2020-12-08T10:32:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/company-coronavirus-news-summary-relief-neurorx-complete-enrolment-for-critical-covid-19-drug-trial-canada-doubles-its-vaccine-supply-agreement-with-moderna/ 2020-12-08T09:02:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-67-5-million-us-cases-near-15-million/ 2020-12-08T09:02:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/investing-in-innovative-biotechs-with-novo-ventures 2020-12-09T13:58:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-disparity-drives-covid-vaccine-distribution-inequality/ 2020-12-08T07:57:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/vaccine-efforts-curb-virus-surge/ 2020-12-08T07:15:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inovio-initiates-dosing-trial/ 2023-01-24T16:37:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-guatemala/ 2024-04-04T04:05:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/creating-and-implementing-a-clinical-data-pipeline-strategy-taming-data-chaos/ 2020-12-17T13:59:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-67-1-million-more-than-14-7-million-in-us/ 2020-12-07T14:10:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/unmet-needs-in-ulcerative-colitis/ 2020-12-07T15:15:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-collaborates-unitedhealth/ 2020-12-21T11:19:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ulcerative-colitis-pipeline-2/ 2022-12-07T14:32:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sinovac-funding-covid-19/ 2021-10-27T12:50:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ulcerative-colitis-pipeline/ 2020-12-07T09:51:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-67-million-uk-to-administer-first-vaccinations-on-tuesday/ 2020-12-07T08:58:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/company-coronavirus-news-summary-moderna-and-israel-expands-covid-19-vaccine-supply-agreement-india-grants-emergency-approval-to-pfizers-covid-19-vaccine/ 2020-12-07T08:26:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/unequal-access-understanding-cancer-treatment-disparity-in-europe/ 2020-12-03T15:31:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-management-skills-can-help-reduce-covid-impact/ 2020-12-07T07:44:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/managerial-talent-can-help-weather-covid-19-shocks-leading-macroeconomic-influencers/ 2020-12-07T07:18:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-eua-dcgi-india/ 2020-12-07T11:59:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/kazakhstan-pursues-diversification-agenda/ 2020-12-11T16:46:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inovio-deal-kaneka-eurogentec/ 2020-12-04T14:51:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/trustpilot-for-medicines-can-drugsdiscovered-help-pharma-be-patient-centric/ 2023-01-24T16:37:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/global-data-epidemiologist-report-global-covid-cases-pass-65-3-million-us-exceeds-14-million/ 2020-12-04T13:35:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sage-mdd-zuranolone-biogen/ 2021-11-22T09:31:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-65-million-more-than-1-5-million-deaths/ 2020-12-04T11:19:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ku-leuven-partner-batavia/ 2020-12-04T11:18:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pfizer-biontech-covid-vaccine-uk/ 2020-12-04T10:33:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-inovio-expands-covid-19-vaccine-global-manufacturing-capacity-daewoong-eyes-phase-ii-studies-of-anti-parasitic-drug/ 2020-12-04T09:03:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-coronavirus-created-us-unemployment-crisis/ 2020-12-04T08:26:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-shrinks-us-labour-market/ 2020-12-04T08:09:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/niaid-moderna-mrna-1273/ 2020-12-04T08:42:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/industry-4-0-ready/ 2020-12-04T14:32:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-will-biden-deliver-on-esg-pledges/ 2024-04-04T04:07:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-honduras/ 2024-04-04T04:08:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-64-6-million-deaths-rise-in-germany-hungary-and-austria/ 2020-12-03T14:40:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-buys-bamlanivimab-covid/ 2020-12-03T14:37:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ai-models-treatment-practices/ 2020-12-03T15:57:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/eliminating-digital-challenges-and-connecting-workers-in-areas-like-manufacturing-and-healthcare/ 2020-12-03T12:08:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/mrna-vaccines-covid19-pandemic-curevac/ 2020-12-05T14:47:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hepatocellular-carcinoma-unmet-needs/ 2020-12-03T10:20:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-pfizer-biontechs-vaccine-approved-in-the-uk-us-buys-650000-doses-of-lillys-neutralising-antibody/ 2021-10-29T08:13:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-64-5-million-deaths-near-1-5-million/ 2020-12-03T09:16:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/predicting-covid-19-vaccine-approvals-with-opyl/ 2020-11-19T13:42:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-rhizen-pharmaceuticals-application/ 2020-12-03T08:36:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-covid-could-lead-to-wartime-levels-of-government-borrowing/ 2020-12-03T08:29:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-resurgence-slows-us-economic-activity/ 2020-12-03T08:29:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dcgi-probe-sii-vaccine/ 2020-12-03T12:19:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-romania/ 2024-04-04T04:08:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-mrna-vaccines/ 2020-12-02T16:09:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/continuous-manufacturing-of-biologics-2020/ 2020-12-02T15:55:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-64-million-deaths-on-the-increase/ 2020-12-02T15:42:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pfizer-covid-19-vaccine-approved-uk/ 2020-12-02T15:11:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-vaccines-forecast-sales-therapeutic-drugs/ 2020-12-02T14:56:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/butterworth-labs-on-leading-the-charge-toward-pharma-sustainability/ 2020-12-04T10:04:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boston-scientific-sell-btg/ 2021-11-02T06:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-biontech-covid-19/ 2020-12-02T10:19:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-near-64-million-us-records-100000-cases-daily/ 2020-12-02T09:55:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-covid-cases-increase/ 2020-12-02T09:21:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-pfizer-biontech-seeks-conditional-approval-in-europe-for-covid-19-vaccine-dr-reddys-starts-sputnik-v-vaccine-trial-in-india/ 2020-12-02T09:20:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/synox-emactuzumab-rare-cancer 2020-12-01T13:10:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/lack-of-work-from-home-opportunities-increases-pandemic-risk-in-developing-countries/ 2020-12-02T07:23:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-rolling-review-janssen/ 2020-12-02T07:22:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/low-prevalence-remote-working/ 2020-12-15T11:51:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-uzbekistan/ 2024-04-04T04:11:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-63-3-million-confirmed-cases-increasing-daily-in-eastern-europe/ 2020-12-01T13:46:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-forxiga-approval-japan/ 2020-12-01T13:23:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-63-3-million-more-than-1-47-million-deaths/ 2020-12-01T12:45:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-sells-products-celltrion/ 2020-12-01T13:16:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/will-there-ever-be-an-hiv-vaccine/ 2023-01-09T04:10:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/brolucizumab-diabetic-macular-oedema/ 2020-12-01T09:42:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-moderna-to-seek-early-and-conditional-approval-in-the-us-and-europe-for-its-covid-19-vaccine-regeneron-and-upenn-study-intranasal-administration-of-covid-19-antibo/ 2020-12-01T09:24:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/new-covid-surge-heaps-pressure-on-us-economy/ 2020-12-01T08:57:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/us-double-dip-recession-dollar-crash/ 2020-12-01T08:40:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-vaccine-efficacy-data/ 2020-12-01T07:48:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/market-access-in-china-an-increasingly-dynamic-environment-html/ 2021-11-02T03:18:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-slovakia/ 2024-04-04T04:12:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-impact-will-office-of-investment-have-uk-fdi/ 2020-11-30T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rdif-hetero-sputnik-v/ 2020-11-30T14:03:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/moderna-to-seek-early-and-conditional-approval-in-the-us-and-europe-for-its-covid-19-vaccine/ 2020-11-30T13:44:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/veeva-2020-commercial-summit/ 2020-11-30T13:08:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-deal-sage-therapeutics/ 2020-11-30T11:28:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-62-7-million-deaths-exceed-1-45-million/ 2020-11-30T10:19:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-malaysia-signs-a-supply-deal-with-pfizer-recovery-trial-adds-another-drug-colchicine/ 2020-11-30T09:15:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/special-delivery-the-logistics-of-curing-covid-19/ 2023-01-24T16:37:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-causes-first-swedish-life-expectancy-fall-in-more-than-a-century/ 2020-11-30T07:54:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/swedish-life-expectancy-macroeconomic-influencers/ 2020-11-30T07:35:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-signs-deal-uk/ 2020-11-30T11:27:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/gerteis-roller-compactors/ 2020-11-30T14:36:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-nicaragua/ 2020-11-29T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-merck-application-tepotinib/ 2020-11-27T14:26:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-61-million-germany-exceeds-one-million-infections/ 2020-11-27T11:34:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bioinvent-antibody-deal-cantargia/ 2020-11-27T12:01:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-indias-first-covid-19-vaccine-enters-phase-iii-trials-ukraine-seeks-world-bank-loan-to-sign-covid-19-vaccine-agreements/ 2020-11-27T09:41:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/second-covid-lockdown-less-painful-than-the-first-for-uk-gdp/ 2020-11-27T07:39:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/uk-economy-lockdowns/ 2020-11-27T07:13:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-low-dose-trial/ 2020-11-27T08:04:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cxv-global-covid-19-response/ 2020-11-27T10:37:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/hvac-and-cleanroom-design/ 2020-11-27T11:49:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-massachusetts/ 2020-11-26T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/uk-spending-review-science-research-development/ 2020-11-28T09:37:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/altimmune-fda-vaccine-candidate/ 2020-11-26T13:55:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/covaxx-vaccine-purchase-deals/ 2020-11-26T11:31:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/fdi-drivers-and-political-stability/ 2020-12-11T17:46:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-rise-of-gout-examining-drug-development-for-an-age-old-disease/ 2022-12-03T09:43:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-covaxx-signs-vaccine-supply-deal-with-developing-countries-moderna-and-the-european-commission-confirm-their-vaccine-supply-deal/ 2020-11-26T08:57:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-60-million-surge-continues-in-us/ 2020-11-26T08:32:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-third-wave-likely-for-uk-after-christmas-warn-scientists/ 2020-11-26T07:09:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-fosun-pharma-trial/ 2020-11-26T08:29:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/uk-third-wave-covid-christmas/ 2020-11-26T06:51:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/implementing-the-ballroom-concept-for-biomanufacturing-lessons-reflections-and-considerations-from-experience/ 2024-07-01T16:18:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-cases-us-vaccines/ 2020-11-25T16:26:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bio-pharma-market-cap-q3-2020/ 2020-11-25T16:13:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/undiagnosed-asthma-cases-uk/ 2020-11-25T15:44:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-xofluza-fda-approval/ 2020-11-25T17:48:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/biomarin-deep-genomics-ai-rare-disease 2023-06-15T04:10:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-59-8-million-fears-of-second-wave-across-africa/ 2020-11-25T13:28:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/purdue-pharma-guilty-charges/ 2020-11-26T08:59:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-lilly-signs-a-260000-dose-supply-deal-with-canada-moderna-finalises-vaccine-supply-deal-with-the-ec/ 2020-11-25T09:08:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-59-7-million-us-faces-third-wave/ 2020-11-25T08:24:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-covid-increases-us-urban-inequality/ 2020-11-25T07:34:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-urban-income-inequalities/ 2020-11-25T07:14:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eu-moderna-vaccine-deal/ 2020-11-26T13:25:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/will-the-uk-investment-bill-impede-investors/ 2020-11-24T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/proposed-lowering-of-colorectal-cancer-screening-to-age-45-may-drive-increase-in-cases/ 2023-02-28T05:08:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/companies-should-be-free-to-bid-on-federally-funded-healthcare-contracts-poll/ 2020-11-25T06:34:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/joe-bidens-win-and-democratic-control-over-congress-will-lead-to-lower-healthcare-costs-poll/ 2020-11-25T06:35:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-covid-19-cases-flu-falls/ 2020-11-24T14:22:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-59-3-million-third-wave-hits-south-korea/ 2020-11-24T14:06:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hifibio-pharmsynthez-ibch-deal/ 2020-11-24T13:11:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/veridata-edc-elseviers-electronic-data-capture-software-puts-compliance-front-and-centre/ 2020-11-24T11:01:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-to-buy-oncoimmune/ 2020-11-24T10:32:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/is-quantum-computing-pharmas-next-big-disruptor/ 2020-11-24T09:57:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-astrazeneca-to-submit-its-covid-19-vaccine-for-early-or-conditional-approval-globally-curevac-signs-manufacturing-agreement-with-wacker-chemie/ 2020-11-24T09:24:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-59-million-deaths-approach-1-4-million/ 2020-11-24T08:52:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-covid-affects-private-debt-and-unemployment/ 2020-11-24T07:42:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-vaccine-efficacy/ 2020-11-24T08:38:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/tackling-private-debt-covid/ 2020-11-24T07:23:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-the-czech-republic/ 2020-11-23T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/silicone-for-implantable-drug-delivery-best-materials-and-modifications/ 2024-06-18T15:43:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/elseviers-electronic-data-capture-solution-ensures-high-quality-data-management-in-clinical-studies/ 2020-11-23T17:00:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-elections-not-to-impact-the-call-for-change-in-regulations-to-improve-access-to-telemedicine-poll/ 2023-05-25T03:56:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medicare-for-all-and-public-option-for-healthcare-the-best-healthcare-plan-outcome-of-the-us-presidential-election-poll/ 2022-07-18T10:20:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/biggest-influencers-in-healthtech-in-q3-2020-the-top-individuals-to-follow/ 2023-02-23T05:32:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-biontech-fda-eua/ 2020-11-23T14:18:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-58-7-million-concerns-over-post-thanksgiving-spike-in-us/ 2020-11-23T13:42:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/astrazenecas-covid-19-vaccine-achieves-up-to-90-interim-efficacy/ 2020-11-23T11:36:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mesoblast-deal-novartis/ 2021-11-26T05:01:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-58-7-million-hundreds-of-unclaimed-bodies-in-nyc/ 2020-11-23T10:48:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/drugs-or-non-drug-alternatives-how-should-we-treat-chronic-primary-pain-in-the-uk/ 2020-11-23T09:09:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-regenerons-antibody-cocktail-receives-eua-from-fda-pfizer-and-biontech-submit-eua-to-the-fda-for-covid-19-vaccine/ 2020-11-23T08:56:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-economic-shock-data-may-be-misinterpreted/ 2020-11-23T08:25:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/income-inequalities-advanced-economies/ 2020-11-23T07:15:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-eua-regeneron-cocktail/ 2020-11-23T08:02:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-cameroon/ 2020-11-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fdi-drivers-and-the-quest-for-talent/ 2020-11-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/finerenone-risk-cardiovascular-type-2-diabetes-kidney-disease/ 2023-03-09T06:12:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-arthritis-drug-trial/ 2020-11-20T16:22:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pre-existing-cardiovascular-disease-mortality-covid-19/ 2020-11-23T08:52:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-57-million-india-exceeds-nine-million/ 2020-11-20T13:01:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-eua-lilly-baricitinib/ 2020-11-20T10:08:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-arthritis-drug-effective-in-treating-sickest-covid-19-patients-anti-covid-19-nasal-spray-ready-for-use-in-humans/ 2020-11-20T09:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/londons-economic-recovery-weakest-in-uk/ 2020-11-20T09:04:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/london-experiences-weaker-recovery/ 2020-11-20T08:59:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-oxford-immune-response/ 2020-11-20T07:40:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-ontario/ 2020-11-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-trial-spain/ 2020-11-19T15:48:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/new-treatment-modalities-clinical-development-pancreatic-cancer/ 2022-01-24T13:29:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-56-3-million-brazil-nears-6-million-infections/ 2020-11-19T13:24:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aha-2020-omega-3-no-cardiovascular-benefits/ 2020-11-19T11:22:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/millions-face-us-unemployment-support-shortfall/ 2020-11-19T11:14:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/university-of-oxford-reports-promising-results-in-older-adults-in-phase-ii-vaccine-trial/ 2020-11-19T11:13:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/federal-unemployment-aid/ 2020-11-19T10:48:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-samsung-bioepis-biogen/ 2020-11-19T10:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-56-3-million-us-fatalities-exceed-quarter-of-a-million/ 2020-11-19T10:04:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/merck-velosbio-ror1-cancer 2020-11-18T09:41:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-pfizer-biontech-to-file-for-eua-in-the-us-for-covid-19-vaccine-relief-therapeutics-finds-partners-for-european-clinical-trials-of-rlf-100/ 2020-11-19T09:10:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-biontech-covid-trial/ 2020-11-19T06:57:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-switzerland/ 2020-11-18T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-the-abu-dhabi-governments-approach-to-fdi-is-succeeding/ 2021-06-25T10:22:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ptf-the-logistics-of-curing-covid-19/ 2023-01-24T16:38:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/why-going-digital-is-the-right-step-for-the-pharma-industry/ 2021-06-21T08:14:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/pfizer-biontech-to-file-for-eua-in-us-for-covid-19-vaccine/ 2020-11-18T13:48:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sinovac-coronavac-trial/ 2023-01-24T16:38:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-55-7-million-infections-in-india-near-9-million/ 2020-11-18T13:28:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/amgen-omecamtiv-mecarbil-clinical-outcome/ 2020-11-18T12:32:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/workplace-wearables%ef%b8%8f-connect-active-workers/ 2020-11-18T16:58:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-55-6-million-us-death-toll-nears-quarter-million/ 2020-11-18T11:18:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-myokardia-13-1bn/ 2021-11-22T06:02:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/zolgensma-regenxbio-novartis 2022-03-23T10:23:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/calliditas-genkyotex-rare-disease 2023-05-29T05:33:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-fda-to-be-transparent-about-eua-process-for-covid-19-drugs-and-vaccines-moderna-signs-supply-deal-with-the-uk/ 2020-11-18T09:01:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-covid-restrictions-disproportionately-affect-the-young/ 2020-11-18T08:26:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/generation-covid-economic-fallout/ 2020-11-18T07:55:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/redhill-biopharma-initiate-trial/ 2020-11-18T07:25:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-illinois/ 2020-11-17T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-55-2-million-pandemic-control-possible-mid-2022-says-biontech-ceo/ 2020-11-17T18:06:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/precision-medical-wire-in-pacemakers/ 2021-09-08T15:36:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pharma-digital-pharma-twitter/ 2020-11-17T15:03:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lead-pharma-roche-deal/ 2020-11-17T14:42:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-55-1-million-uruguay-leads-way-in-virus-control/ 2020-11-17T13:28:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/samsung-biologics-deal-lilly/ 2020-11-23T09:31:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-secures-5m-doses-of-modernas-covid-19-vaccine-mrna-1273/ 2020-11-17T09:31:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/breast-cancer-breakthrough-could-a-new-therapy-silence-stubborn-tnbc/ 2020-10-27T17:24:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-moderna-publishes-early-efficacy-data-for-covid-19-vaccine-lilly-and-samsung-biologics-sign-long-term-production-agreement/ 2020-11-17T08:51:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-storage-temperature-could-give-modernas-covid-vaccine-the-edge/ 2020-11-17T08:15:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/modernas-coronavirus-vaccine/ 2020-11-17T07:01:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biological-e-covid-19/ 2020-11-17T06:18:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/sdg-focus-covid-19-wider-health-impact/ 2020-11-17T05:58:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/southampton-university-sng001/ 2022-10-07T11:03:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-infections-near-54-5-million-more-than-one-million-cases-in-11-countries/ 2020-11-16T14:41:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/moderna-publishes-interim-phase-iii-results-showing-94-5-efficacy-from-covid-19-vaccine/ 2020-11-16T14:33:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-keytruda-fda-approval/ 2021-10-25T08:52:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/abrocitinib-pfizer-jak-inhibitors/ 2021-09-10T11:56:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/akebia-anaemia-vadadustat/ 2021-12-02T06:33:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-kalas-eysuvis-dry-eye-syndrome/ 2020-11-16T10:20:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/astrazeneca-fusion-radiopharmaceuticals 2020-11-12T11:31:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-54-4-million-us-cases-rise-one-million-in-one-week/ 2020-11-16T09:52:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-switzerland-to-conduct-a-rolling-review-of-modernas-covid-19-vaccine-rdif-signs-a-production-agreement-with-south-korean-gl-raph-for-sputnik-v-vaccine/ 2020-11-16T09:12:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-government-called-to-stamp-out-anti-vaccine-messaging/ 2020-11-16T08:22:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/labour-emergency-laws-anti-vaccination/ 2020-11-16T10:37:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/will-the-winner-take-it-all-in-the-covid-vaccine-race/ 2020-11-16T06:06:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-ensemble-2-trial/ 2023-01-24T16:38:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-british-columbia/ 2020-11-15T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-approach-53-million-france-nears-2-million/ 2020-11-13T14:41:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/world-diabetes-day-2020-despite-covid-19-the-diabetes-market-continues-to-evolve-rapidly/ 2023-05-22T08:39:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gmax-biopharm-pah-early-stage-drug/ 2020-11-13T12:01:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-belgium/ 2020-11-12T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-approval-provention-bio-teplizumab-type-1-diabetes/ 2020-11-12T17:17:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-may-have-a-negative-effect-on-branded-diabetes-drug-sales/ 2020-11-12T17:02:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pfizer-biontech-covid-19-vaccine-unanswered-questions/ 2020-11-15T09:29:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/taiho-lung-therapeutics-japan/ 2020-11-12T15:23:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-52-2-million-upward-trend-in-eu/ 2020-11-12T13:07:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/imcr-sii-novavax-india/ 2020-11-12T11:41:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-surge-past-52-1-million-us-confirms-highest-24-hour-infection-rate-to-date/ 2020-11-12T10:38:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/no-need-for-animal-testing-improving-vaccine-research-with-genoskin/ 2020-11-12T10:47:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronvirus-company-news-summary-eu-signs-vaccine-supply-deal-with-pfizer-and-biontech-rdif-announces-sputnik-v-vaccine-achieved-92-efficacy-in-phase-iii-trials/ 2020-11-12T09:01:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-economic-tools-are-helping-fight-covid/ 2020-11-12T08:38:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/economic-tools-response-covid/ 2020-11-12T08:07:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sinovac-restart-brazil-trial/ 2023-01-24T16:39:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/pfizer-and-biontechs-covid19-vaccine-html/ 2022-02-22T09:00:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-ecuador/ 2020-11-11T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/could-covid-19-kill-the-investment-treaty/ 2020-11-11T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pfizer-and-biontechs-covid-19-vaccine-candidate-shows-90-efficacy-raising-expectation-for-mrna-vaccines/ 2020-11-12T11:19:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-biontech-vaccine-supply-agreement/ 2020-11-11T15:40:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/merck-oncology-velosbio-portfolio/ 2021-11-25T10:48:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-51-5-million-more-than-200000-in-one-day-in-us/ 2020-11-11T16:37:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-51-4-million-100000-cases-per-day-in-us/ 2020-11-11T10:11:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/lumen-spirulina-antibodies-covid-19/ 2020-11-12T08:53:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-atossa-and-medicago-separately-publish-positive-result-of-their-respective-phase-i-covid-19-vaccine-studies/ 2020-11-11T09:13:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adagio-therapeutics-covid-19-antibodies/ 2020-11-11T09:10:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-covid-is-ending-the-self-employment-boom/ 2020-11-11T08:17:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/women-disproportionately-impacted-covid/ 2020-11-11T07:57:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/indian-researchers-sars-cov-2/ 2020-11-11T08:01:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-turkey/ 2020-11-10T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bridge-biotherapeutics-boehringer/ 2021-11-24T03:34:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-near-51-million-huge-rises-in-us-and-uk/ 2020-11-10T13:22:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-eua-lilly-antibody/ 2020-11-10T11:00:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-us-and-europe-to-get-first-doses-of-pfizer-biontech-covid-vaccine-russia-claims-sputnik-v-vaccine-more-than-90-effective/ 2020-11-10T10:12:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/avastin-tecentriq-combination-approval-china-europe/ 2020-11-10T10:07:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-covid-19-has-put-clinical-researchs-diversity-problem-in-the-spotlight/ 2020-11-12T13:53:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-pfizer-biontech-announce-promising-results-for-covid-19-vaccine-fda-grants-eua-to-lilly-for-neutralising-antibodies-in-mild-and-moderate-patients/ 2020-11-10T09:04:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-us-unemployment-systems-are-failing-claimants/ 2020-11-10T07:44:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/federal-policymakers-economy-covid/ 2020-11-10T07:08:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-50-5-million-us-exceeds-10-million/ 2020-11-10T06:38:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immunitybio-reports-positive-data/ 2020-11-10T06:30:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-bulgaria/ 2020-11-09T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/us-election-2020/pharma-reacts-to-biden-becoming-46th-us-president/ 2020-11-12T15:12:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/blockchain-enabled-hospital-china/ 2020-11-09T14:57:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/pfizer-biontech-report-covid-19-vaccine-was-at-least-90-effective-in-phase-iii-study/ 2020-11-09T14:33:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/humanigen-signs-deal-us/ 2021-03-30T05:28:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-50-million-us-nears-10-million/ 2020-11-09T11:32:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-novartiss-canakinumab-fails-to-meet-endpoints-in-covid-19-trial-aspirin-added-to-the-uks-recovery-trial/ 2020-11-09T09:27:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-to-combat-vaccine-hesitancy-in-the-age-of-covid-19/ 2020-11-11T17:05:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biden-ows-us-election/ 2020-11-09T12:11:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/long-hcc-pipeline/ 2022-03-24T12:33:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/killing-zombies-in-the-time-of-covid-the-hidden-dangers/ 2020-11-09T08:11:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/us-jobless-claims-covid/ 2020-11-09T07:40:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/australia-covid-19-vaccine/ 2020-11-09T12:13:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fdi-drivers-and-political-stability-2/ 2020-11-08T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-quebec/ 2020-11-08T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bangladesh-deal-serum-institute/ 2020-11-06T14:05:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-48-6-million-us-surge-in-trump-voting-counties/ 2020-11-06T10:55:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-to-acquire-velosbio/ 2020-11-06T09:29:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/nsclc-unmet-needs-opportunities/ 2022-07-29T11:12:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-neurorx-and-reliefs-allowed-to-fully-enrol-rlf-100-trial-bangladesh-signs-access-agreement-with-sii/ 2020-11-06T09:08:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-insecure-jobs-help-to-spread-covid-19/ 2020-11-06T08:32:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-work-reality/ 2020-11-06T08:30:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biogen-aducanumab-fda-approval/ 2020-11-06T08:17:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-continue-regn-cov2/ 2020-11-06T08:25:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/has-trump-destroyed-the-globalisation-dream/ 2020-11-05T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-south-korea/ 2020-11-05T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-will-workforces-emerge-from-the-covid-crisis/ 2020-11-05T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/citizenship-for-sale-how-investment-buys-passports/ 2020-11-05T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-48-2-million-record-daily-highs-in-us/ 2020-11-05T14:39:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-astrazeneca-merck-lynparza/ 2022-12-02T15:08:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-europe-seasonality/ 2020-11-05T13:06:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/australia-novavax-nvx-cov2373/ 2020-11-05T12:26:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-48-million-record-infections-in-six-european-nations/ 2020-11-05T10:30:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-trumps-ratings-fell-as-the-us-economy-rose/ 2020-11-05T10:19:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-novavax-signs-a-supply-deal-with-australia-peru-and-chile-to-start-trials-of-astrazeneca-and-jjs-covid-19-vaccines/ 2020-11-05T09:40:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/atomwise-qa/ 2023-03-03T11:46:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/trumps-approval-fall-economy/ 2020-11-05T08:29:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aiims-study-covid-19/ 2020-11-05T08:08:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-47-5-million-substantial-increases-in-europe/ 2020-11-04T13:59:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cepi-clover-covid-vaccine/ 2020-11-04T13:05:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/will-blockchain-reshape-trade-and-investment/ 2020-11-26T11:15:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/humanigen-asia-pacific-market/ 2020-11-04T10:06:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/why-san-francisco-has-become-a-ghost-town/ 2020-11-04T09:23:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/medidata-next-goes-virtual-what-does-the-post-pandemic-future-look-like/ 2022-02-03T16:50:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-jj-given-permission-to-resume-clinical-trial-in-brazil-mexico-signs-deal-with-cansino-for-vaccine-trial/ 2020-11-04T09:03:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/san-francisco-covid/ 2020-11-04T09:01:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brazil-johnson-johnson-trial/ 2023-01-24T16:39:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/2020-bio-investor-forum-digital-spacs/ 2020-11-03T15:10:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-near-47-million-ukraine-and-hungary-post-record-highs/ 2020-11-03T14:15:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-ec-tecentriq-avastin/ 2020-11-03T12:41:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-near-47-million-t-cell-immunity-likely-to-last-six-months/ 2020-11-03T10:10:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-to-acquire-kiadis/ 2020-11-03T10:01:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/iovance-biotherapeutics-til-therapy/ 2020-11-03T09:58:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-curevac-publishes-positive-phase-i-results-of-covid-19-vaccine-aspen-to-support-jj-in-vaccine-manufacturing/ 2020-11-03T09:14:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-for-profits-colleges-are-on-the-rise-in-the-us-why-real-inflation-has-doubled/ 2020-11-03T07:42:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/for-profits-comeback-covid/ 2020-11-03T07:20:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aspen-pharmacare-jj-vaccine/ 2021-10-27T10:42:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-new-york/ 2020-11-02T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-texas/ 2020-11-02T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/america-decides-a-us-election-special/ 2020-11-02T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-approach-47-million-lockdowns-increase-across-europe/ 2020-11-02T15:30:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-46-6-million-trump-blamed-for-us-infection-spikes/ 2020-11-02T14:01:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-eisai-ema-alzheimers/ 2020-11-02T14:12:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/coronavirus-second-wave-lockdowns/ 2020-11-02T10:29:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/laryngeal-cancer-pipeline/ 2023-05-29T05:01:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/araris-adcs-oncology-seed-round 2022-11-04T16:45:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-regeneron-to-stop-enrolling-critically-ill-patients-into-antibody-trial-lonzo-and-astrazeneca-to-partner-on-antibody-drug-studies/ 2020-11-02T09:13:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/investers-need-to-adjust-expectations-during-covid-pandemic/ 2020-11-02T08:40:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/covid-19-us-election/ 2020-11-02T09:39:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/prolonged-recession-asset-performance/ 2020-11-02T07:47:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-rolling-review-astrazeneca/ 2020-11-02T08:08:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/unctad-reports-plummeting-fdi-in-first-half-of-2020/ 2020-11-01T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/which-countries-crumble-if-their-manufacturing-industry-falls/ 2020-11-01T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/invasive-meningococcal-disease-reduction/ 2020-10-30T13:39:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-novo-nordisk-obesity/ 2020-10-30T13:11:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-45-1-million-us-nears-9-million/ 2020-10-30T12:29:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/qa-with-calliditas-what-impact-will-the-us-election-have-on-pharma/ 2020-10-30T10:15:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-takeda-vaccine-japan/ 2020-10-30T09:59:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fujifilm-disease-manufacturing-2020/ 2020-10-30T09:47:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-takeda-japanese-government-and-moderna-sign-supply-deal-for-mrna-1273-dr-reddys-initiates-partnership-with-birac-for-sputnik-v-trials/ 2020-10-30T09:24:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-scars-caused-by-covid-will-be-slow-to-heal/ 2020-10-30T09:00:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/economy-covid-scars/ 2020-10-30T08:23:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/drug-donations-us-election/ 2020-10-30T08:30:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-would-a-biden-presidency-impact-foreign-investment/ 2020-10-29T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/replace-gxp-sftp-file-servers-with-modern-solutions-for-validated-environments/ 2020-11-07T03:19:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-vaccine-us-presidential-election/ 2020-10-29T15:28:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-44-5-million-more-than-1-1-million-deaths/ 2020-10-29T12:27:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cstone-legochem-team-up/ 2020-10-29T12:16:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cryopdps-laboratory-move-solution-protects-the-integrity-of-biomaterials/ 2021-10-14T18:23:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-molecular-partners-deal/ 2020-10-29T12:16:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-near-44-5-million-uk-cases-approach-1-million/ 2020-10-29T09:16:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/b-cell-therapies-series-a 2020-10-29T09:00:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-sanofi-and-gsk-to-supply-vaccines-to-covax-facility-lilly-to-sign-supply-deal-for-ly-cov555-with-us-government/ 2020-10-29T08:59:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/why-governments-should-think-big-how-gdp-growth-figures-can-be-misleading/ 2020-10-29T08:04:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-supply-deal-us/ 2020-10-29T08:11:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-recovery-bigger-thinking/ 2020-10-29T07:26:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-kuwait/ 2020-10-28T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/can-fdi-data-be-trusted/ 2020-10-28T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/us-election-2020/trump-pandemic-covid-19-politics-us-election/ 2020-10-28T17:02:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiology-report-global-covid-cases-pass-44-1-million-record-daily-increases-across-europe/ 2020-10-28T15:55:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apellis-drug-deal-sobi/ 2021-12-02T05:57:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-44-million-cases-in-india-near-8-million/ 2020-10-28T11:37:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/russia-who-sputnik-v/ 2020-10-28T10:38:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/us-election-healthcare-biden-trump/ 2020-11-09T10:08:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-mhra-to-conduct-a-rolling-review-of-modernas-covid-19-vaccine-histogen-to-study-emricasan-in-covid-19-patients/ 2020-10-28T09:28:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/moderna-covid-vaccine-takes-lead/ 2020-10-28T09:16:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-us-latinx-workers-are-disproportionately-affected-by-covid-19/ 2020-10-28T08:59:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/latinx-job-losses-covid/ 2020-10-28T08:45:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/italy-osteoporosis-drug-covid/ 2023-01-17T10:03:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-sweden/ 2020-10-27T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/breast-cancer-awareness-month-2020/ 2020-10-27T14:59:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-vaccine-deal-qatar/ 2020-10-27T11:04:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aurobindo-pharma-sell-natrol/ 2021-10-28T07:49:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-43-5-million-who-warns-of-pandemic-fatigue/ 2020-10-27T09:12:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/t-cell-twist-neogene-partnership 2022-07-22T10:27:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-nih-halts-enrolment-of-trial-of-lillys-covid-19-monoclonal-antibody-drug-astrazeneca-reports-promising-immunogenicity-data-in-older-adults-for-covid-19-vaccine/ 2020-10-27T08:49:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/why-global-gdp-growth-forecast-is-misleading/ 2020-10-27T07:50:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/global-gdp-growth-covid/ 2020-10-27T07:24:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ana-therapeutics-niclosamide-covid/ 2020-10-27T08:03:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fdi-drivers-and-barriers-in-the-business-environment/ 2020-10-26T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-jamaica/ 2020-10-26T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-43-1-million-more-than-8-6-million-in-us/ 2020-10-26T15:27:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/us-election-2020/us-election-covid-19/ 2020-10-26T14:37:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-acquires-askbio-4bn/ 2020-10-27T08:22:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-43-1-million-europe-posts-record-one-day-high/ 2020-10-26T12:35:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/why-covid-vaccine-is-key-to-economic-recovery-how-uk-support-plan-is-flawed/ 2020-10-26T11:13:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-vaccine-macroeconomic-influencers-2/ 2020-10-26T10:54:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-sciences-acquires-immunomedics/ 2021-11-25T10:39:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-astrazenecas-vaccine-trial-restarts-in-the-us-canadian-government-grants-funding-to-two-covid-19-vaccines/ 2020-10-26T09:25:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/exscientia-blue-oak-cns-partnership 2020-10-26T09:26:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-election-covid-approvals/ 2020-10-26T09:01:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-fda-covid-19/ 2020-10-26T08:24:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/mixed-news-on-covid19-vaccines-covid19-rd-tracker-html/ 2021-11-02T03:18:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-hong-kong/ 2020-10-25T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-eurofins-cdmo-is-overcoming-the-challenges-of-high-potency-drug-manufacturing/ 2021-11-10T12:52:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-vaccines-cmos/ 2020-10-23T15:29:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/water-for-injections-puretech/ 2020-12-10T10:39:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/peru-covid-deal-astrazeneca/ 2020-10-23T13:28:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-near-41-8-million-significant-rise-in-germany/ 2020-10-23T12:55:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-covid-is-creating-an-age-based-unemployment-gap-in-us/ 2020-10-23T11:12:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-41-7-million-record-daily-rises-across-europe/ 2020-10-23T10:53:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dr-reddys-cyber-attack/ 2021-10-27T11:22:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-gileads-remdesivir-is-approved-by-the-fda-roche-and-atea-team-up-on-covid-19-daa/ 2020-10-23T09:49:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bharat-biotech-cdsco-nod/ 2020-10-23T07:19:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/older-workers-higher-unemployment/ 2020-10-23T07:06:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-poland/ 2020-10-22T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eu-jj-covid-vaccine/ 2020-10-22T13:30:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/purdue-pharma-doj-opioid/ 2020-10-22T11:15:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-ecuador-signs-covid-19-supply-deals-astrazeneca-vaccine-trial-to-continue-despite-death-of-brazilian-participant-in-placebo-group/ 2020-10-22T09:56:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-41-million-france-and-spain-exceed-one-million-infections/ 2020-10-22T15:08:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/maternal-vaccination-rates-us/ 2020-10-22T08:16:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/chord-nmosd-series-a-omega 2020-10-22T13:13:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immunitybio-nantkwest-covid/ 2020-10-22T07:13:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/recession-europe-heads-for-double-dip-us-fails-to-learn-from-2008-9/ 2020-10-22T07:09:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/gdp-europe-double-dip/ 2020-10-22T06:48:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-japan/ 2020-10-21T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eu-horizon-2020-drug-development-research/ 2020-10-21T14:40:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-poland-test-rates/ 2020-10-21T13:50:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-40-8-million-lockdowns-increasing/ 2020-10-21T13:42:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-branaplam-orphan-drug/ 2020-10-21T13:20:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-40-8-million-spain-nears-one-million-infections/ 2020-10-21T11:26:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-parexel-and-synairgen-sign-partnership-for-covid-19-drugs-eib-invests-into-immunics-covid-19-drug/ 2020-10-21T11:01:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-hvivo-covid-19/ 2020-10-21T10:56:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/symvivo-oral-covid-19/ 2020-10-21T09:27:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/rappta-pp2a-cancer-series-a-round 2020-10-21T08:42:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/governments-need-to-act-to-avoid-long-economic-covid/ 2020-10-21T07:48:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/world-economy-support/ 2020-10-21T07:24:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pandemic-redundancy-supply-chain/ 2023-01-24T16:39:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/endo-biospecifics-deal/ 2020-10-20T14:40:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-vaccine-doses-us/ 2020-10-20T13:49:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/why-the-pharma-industry-needs-monitoring-tech-for-its-cold-storage-products/ 2020-12-02T16:53:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/russia-chumakov-center-covid-19/ 2020-10-20T09:50:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/double-dip-recession-looms-for-europe-post-covid/ 2020-10-20T09:16:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/europe-double-dip-recession/ 2020-10-20T09:03:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-40-4-million-us-may-authorize-emergency-use-of-vaccine-in-december/ 2020-10-20T08:45:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-evotec-receives-gates-foundation-funding-for-covid-19-antibody-drugs/ 2020-10-20T08:18:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/neutralising-the-gluten-threat-are-we-on-the-cusp-of-a-coeliac-disease-breakthrough/ 2023-11-06T05:29:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/edesa-eb05-covid-19/ 2020-10-20T09:07:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/the-us-china-decoupling-inside-the-big-break-up/ 2020-10-19T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-eu-forxiga/ 2020-10-19T15:23:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-vaccines-road-to-recovery-everbridge/ 2020-10-19T14:36:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-40-1-million-rise-in-africa-as-restrictions-eased/ 2020-10-19T13:27:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentech-abbvie-venclexta/ 2020-10-19T11:12:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-40-million-trump-claims-us-is-rounding-the-turn/ 2020-10-19T09:50:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-vaccine-development-trump-biden/ 2020-10-19T08:23:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-india-begin-studying-russias-sputnik-v-covid-19-vaccine-china-to-approve-covid-19-vaccines-for-emergency-use/ 2020-10-19T08:07:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dr-reddys-rdif-sputnik-v/ 2020-10-19T11:08:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-rising-unemployment-rates-point-to-slow-us-recovery-why-obesity-has-made-covid-19-worse-in-the-us/ 2020-10-19T06:50:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/v-shaped-recovery-doubtful/ 2020-10-19T06:34:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-italy/ 2020-10-18T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fate-therapeutics-celyad-car-therapies/ 2022-03-24T12:38:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-fda-covid-19/ 2020-10-16T15:06:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-near-39-million-deaths-approach-1100000/ 2020-10-16T12:56:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/pfizer-plans-to-submit-covid-19-vaccine-for-fda-approval-in-late-november/ 2020-10-16T12:13:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-disarm-therapeutics/ 2020-10-16T11:33:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-near-39-million-rising-case-numbers-across-europe/ 2020-10-16T10:27:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-who-finds-inconclusive-results-for-repurposed-covid-19-drugs-immunitybio-to-advance-its-covid-19-vaccine-into-phase-i/ 2020-10-16T09:04:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/long-covid-stakeholder-collab/ 2020-10-16T08:07:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/yervoy-and-opdivo-combo-cancer/ 2020-10-16T07:11:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immunitybio-covid-19-fda/ 2020-10-16T11:34:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-pandemic-pushes-8-million-into-poverty-in-us/ 2020-10-16T06:27:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/us-millions-poverty-covid/ 2020-10-16T08:56:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-venezuela/ 2024-03-28T02:41:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-inmazeb-ebola-treatment/ 2020-10-15T12:37:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-dashboards/deals-analysis/phenomic-6m-financing-tumour-stroma 2020-10-15T10:42:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-oncology-deal/ 2020-10-15T10:23:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/synairgen-raises-87m-to-support-phase-iii-covid-19-trial/ 2020-10-15T10:20:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-infections-pass-38-5-million-lockdowns-tighten-across-europe/ 2020-10-15T10:04:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-russia-approves-second-vaccine-moderna-allowed-to-apply-for-marketing-authorisation-in-eu/ 2020-10-15T10:46:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/clinical-trials-analysis/deals-analysis/breaking-the-taboo-disrupting-the-fertility-sector 2020-10-15T08:11:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/why-bahrain-is-the-ideal-strategic-hub-for-healthtech/ 2020-10-16T16:33:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-covid-heightens-existing-inequalities/ 2020-10-15T07:32:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/russia-covid-vaccine-2/ 2020-10-15T07:37:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/us-labour-market-inequalities/ 2020-10-16T08:59:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/pfizer-centreone-q-a-andrew-moore/ 2020-11-30T14:04:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-state-of-play-fdi-in-qatar/ 2020-10-14T23:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/remdesivir-alone-or-in-combination-with-other-drugs-considered-most-promising-drug-for-covid-19-poll/ 2020-10-14T15:38:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/confidence-in-reliability-of-data-regarding-covid-19-therapies-remains-moderately-high-poll/ 2020-10-14T15:28:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/us-election-2020/reproductive-health-policies-us-election/ 2020-10-16T09:08:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-38-2-million-rapid-response-to-testing-in-china/ 2020-10-14T13:49:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-medical-grade-silicone-can-transform-transdermal-drug-delivery/ 2022-02-23T10:42:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-rolling-submission/ 2020-10-14T10:47:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pah-market-therapy-pathways/ 2022-09-19T11:15:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-lilly-pauses-covid-19-antibody-drug-trial-moderna-to-submit-covid-19-vaccine-to-health-canada-on-a-rolling-basis/ 2020-10-14T09:19:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ai-enabled-risk-detection-in-pharma-manufacturing/ 2020-10-14T08:51:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-pause-covid/ 2020-10-14T07:57:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-living-standards-damage/ 2020-10-14T06:59:23+00:00 daily 0.2